<DOC>
	<DOC>NCT01701830</DOC>
	<brief_summary>The aim of the study is to evaluate whether a low level of serum omentin-1 is associated with carotid atherosclerosis and mediated by inflammation.</brief_summary>
	<brief_title>Serum Omentin-1 and Carotid Atherosclerosis In Non-Diabetic Chronic Kidney Disease</brief_title>
	<detailed_description>Atherosclerotic cardiovascular disease is markedly increased in chronic kidney disease. There are a lot of risk factor, along with conventional risk factors. Serum onemtin-1 is a adipokine and suggested as a new marker for vascular disease.It has some anti-atherogenic properties. Studies investigating serum omentin-1 level have usually conducted in patients with diabetes mellitus.</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<criteria>between ages of 18 65 years old chronic kidney disease of stage 34 Chronic kidney disease of stage 5 The history of ischemic cardiovascular disease (myocardial infarction, unstable angina, stroke, peripheral artery disease, or cardiovascular revascularization) Severe heart failure Stage 2 hypertension Diabetes mellitus Corticosteroid therapy Severe hepatic disease Smoking Inflammatory disease Acute infectious disease Malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>omentin-1</keyword>
	<keyword>carotid atherosclerosis</keyword>
	<keyword>kidney disease</keyword>
</DOC>